Ionis licenses hepatitis B program to GSK
Go back to Ionis licenses hepatitis B program to GSK| (NASDAQ: IONS) | Delayed: 73.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.82 | 52 Week High | $62.68 | |||
| Open | $73.82 | 52 Week Low | $19.59 | |||
| Day High | $73.82 | P/E | N/A | |||
| Day Low | $73.82 | EPS | $0.00 | |||
| Volume | 768 | |||||

